Pharmaids Pharmaceuticals shareholders and shareholding pattern
BSE: 524572Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹28.78.
28 Oct: open ₹29.90, high ₹29.90, low ₹27.31
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹97 Cr2,774th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.04
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −8.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹6.70 crore of one-off items, the largest of them in the quarter to Jun 2026.
- −21.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.44
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,865
Pharmaids Pharmaceuticals' shareholding pattern for Sep 2026, filed on 16 Oct 2026, with every filing from Dec 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Pharmaids Pharmaceuticals, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters32.99%
- Individuals and others67.01%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Individuals and others
| Per cent | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.55% | 6.55% | 6.94% | 6.62% | 6.68% | 6.68% | 6.68% | 6.65% | 6.65% | 6.65% | 6.62% | 6.62% | 2.19% | 2.19% | 2.19% | 65.90% | 65.84% | 65.81% | 65.80% | 65.65% | 55.56% | 35.44% | 20.70% | 21.08% | 16.54% | 9.94% | 9.25% | 5.64% | 5.56% | 5.19% | 5.22% | 5.22% | 5.14% | 32.99% | 32.99% | 32.99% | 32.99% | 32.99% | |
| Indian promoters | 6.55% | 6.55% | 6.94% | 6.62% | 6.68% | 6.68% | 6.68% | 6.65% | 6.65% | 6.65% | 6.62% | 6.62% | 2.19% | 2.19% | 2.19% | 65.90% | 65.84% | 65.81% | 65.80% | 65.65% | 55.56% | 35.44% | 20.70% | 21.08% | 16.54% | 9.94% | 9.25% | 5.64% | 5.56% | 5.19% | 5.22% | 5.22% | 5.14% | 32.99% | 32.99% | 32.99% | 32.99% | 32.99% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 93.45% | 93.45% | 93.06% | 93.38% | 93.32% | 93.32% | 93.32% | 93.35% | 93.35% | 93.35% | 93.38% | 93.38% | 97.81% | 97.81% | 97.81% | 34.10% | 34.16% | 34.19% | 34.20% | 34.35% | 44.44% | 64.56% | 79.30% | 78.92% | 83.46% | 90.06% | 90.75% | 94.36% | 94.44% | 94.81% | 94.78% | 94.78% | 94.86% | 67.01% | 67.01% | 67.01% | 67.01% | 67.01% |
| Shares in issue | 34,05,500 | 34,05,500 | 34,05,500 | 34,05,500 | 34,05,500 | 34,05,500 | 34,05,500 | 34,05,500 | 34,05,500 | 34,05,500 | 34,05,500 | 34,05,500 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,03,11,234 | 1,30,86,234 | 2,14,86,234 | 2,14,86,234 | 3,52,67,812 | 3,52,67,812 | 3,52,67,812 | 3,52,67,812 | 3,52,67,812 | 3,52,67,812 | 3,52,67,812 | 3,52,67,812 | 3,52,67,812 | 3,52,67,812 | 3,52,67,812 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 14,51,300 | 56,81,852 | 1,40,81,852 | – | 1,86,77,967 | 1,86,77,967 | 1,86,77,766 | – | – | – | – | – | – | – | – |
Pharmaids Pharmaceuticals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Shankarappa Nagaraja Vinaya Babu, 28.52%. The filing names 10 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Shankarappa Nagaraja Vinaya BabuIndividuals and Hindu undivided families | 28.52% | 1,00,58,149 |
| Tumkur Trade Center Private LimitedIndian companies, trusts and others | 4.45% | 15,68,000 |
| Kant RaoIndividuals and Hindu undivided families | 0.02% | 7,300 |
| B. VenkatswamyIndividuals and Hindu undivided families | 0.00% | 1,070 |
Largest public holders of Pharmaids Pharmaceuticals, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SHREEDHARA SHETTYDirectors and their relatives | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 21.64% | 21.64% | 18.70% | 18.70% | 18.70% | 17.04% | 17.04% | 17.04% | 14.53% | 14.53% | 14.53% | 14.53% | 14.53% |
| GOKARAM RAMKRISHNA BALAJIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.06% | 9.06% | 9.06% | 9.06% | 9.06% | 9.06% | 7.99% | 7.99% | 7.99% | 7.99% | 7.99% |
| SMITHA SHETTY SANCHIT SHETTYResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.72% | 7.72% | 7.72% | 7.72% | 7.72% |
| VENKATA BHAGI RAO SADHANALAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 51.82% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.29% |
| MAKAM SREEVALLIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.21% | 2.21% | 2.21% | 2.21% | 2.21% | 2.21% | 2.21% | 2.21% | 2.21% | 2.21% | 2.21% |
| VENU MADHAVA KAPARTHYDirectors and their relatives | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.38% | 4.38% | 4.38% | 6.70% | 4.08% | 4.08% | 2.48% | 2.48% | 2.48% | 2.48% | 2.46% | 2.46% | 2.03% | 2.03% | 2.03% | 2.03% | 2.02% |
| VENKATESH MAHENDRAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% | 1.24% |
| VENKATA RAO SADHANALAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.32% | 4.32% | 4.32% | 4.32% | – |
| Asian HotelsOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.72% | 7.72% | 7.72% | 7.72% | 7.72% | 7.72% | – | – | – | – | – |
| BALAGANGADHARA BIDANAGERE CHANNATHIMMAIAHKey managers | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.84% | – | – | – | – | – |
| MINI MANIKANTANDirectors and their relatives | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | – | – | – | – | – |
| S PRASADKey managers | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.21% | 1.21% | 1.21% | 1.21% | 1.21% | 1.21% | – | – | – | – | – |
| BALAGANGADHARA B CKey managers | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.97% | 3.03% | 3.03% | 1.84% | 1.84% | 1.84% | 1.84% | 1.84% | – | – | – | – | – | – |
| NARASANDRA BASAVARAJAPPA PRADEEPKUMARResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.61% | 4.61% | 3.63% | 5.24% | 5.24% | 3.19% | 3.19% | 3.19% | – | – | – | – | – | – | – | – |
| SUKHIL S MIRJIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.81% | 4.81% | 4.81% | 3.79% | 3.70% | 3.70% | 2.26% | 2.26% | 2.26% | – | – | – | – | – | – | – | – |
| GOVINDARAJA SETTY SRINIVASA MITHRAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.64% | 4.64% | 3.66% | 3.62% | 2.70% | 1.33% | 1.05% | 1.05% | – | – | – | – | – | – | – | – |
| V MAHENDRAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.24% | 1.24% | – | – | – | – | – | – | – | – | – |
| M R MAHADEVANResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.40% | – | 2.68% | 1.63% | 1.63% | – | – | – | – | – | – | – | – | – | – | – |
| SACHIN JAYANT MALDE TEJAS DILIP VED PARAS VRAJLAL SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.28% | 1.39% | 1.52% | – | – | – | – | – | – | – | – | – | – | – |
| PERCY HOMI ITALIA ZAREEN ITALIAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.26% | – | – | – | – | – | – | – | – | – | – | – |
| SHANKARPPA NAGARAJA VINAYA BABUResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 20.63% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| IRAKASANDRA COLONY GANGADHAR MEGHAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.56% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| PERCY HOMI ITALIAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.00% | 2.15% | 1.96% | – | – | – | – | 1.71% | 1.71% | 1.71% | 1.35% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| TOPGAIN FINANCE PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.18% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MALIEMADOM RAMASWAMY IYER MAHADEVANResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.42% | – | 3.40% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MELLANAHALLY SHANKARAPPA VIJAYAKUMARResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.94% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RAVI KUMAR KROVVIDIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.45% | 1.94% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Padmaja Kalyani SadhanalaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.29% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SUREKHA P DAVEResident individuals, up to ₹2 lakh at face value | 1.40% | 1.40% | 1.40% | 1.40% | 1.40% | 1.40% | – | 1.40% | 1.40% | 1.40% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ANIL VISHANJI DEDHIA SANDHYA ANIL DEDHIAResident individuals, up to ₹2 lakh at face value | 1.03% | 1.03% | – | – | – | 1.03% | 1.03% | 1.03% | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SUREKHA DAVEOther non-institutions | – | – | – | – | – | – | 1.40% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MANULA LALWANIOther non-institutions | – | – | 1.69% | 1.69% | 1.69% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ANIL VISHANJI DEDHIAOther non-institutions | – | – | 1.03% | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MANJULA LALWANIOther non-institutions | 1.69% | 1.69% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: VENKATA RAO SADHANALA no longer named, from 4.32%; VENKATA BHAGI RAO SADHANALA newly named at 4.29%; VENU MADHAVA KAPARTHY 2.02%, −0.01 pts